Johnson Matthey (LON:JMAT) Hits New 12-Month High at $3,188.00

Share on StockTwits

Johnson Matthey PLC (LON:JMAT) shares reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 3,188 ($41.65) and last traded at GBX 3,164 ($41.34), with a volume of 672571 shares. The stock had previously closed at GBX 3,128 ($40.87).

Separately, JPMorgan Chase & Co. upped their price objective on Johnson Matthey from GBX 2,300 ($30.05) to GBX 2,600 ($33.97) and gave the company a “neutral” rating in a research report on Friday, November 20th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of GBX 2,585 ($33.77).

The stock has a market capitalization of £6.03 billion and a price-to-earnings ratio of 59.92. The company has a debt-to-equity ratio of 62.64, a quick ratio of 0.77 and a current ratio of 1.28. The firm has a fifty day moving average of GBX 2,884.80 and a 200-day moving average of GBX 2,514.59.

In related news, insider Robert MacLeod purchased 12 shares of the stock in a transaction that occurred on Wednesday, February 17th. The stock was purchased at an average cost of GBX 3,101 ($40.51) per share, for a total transaction of £372.12 ($486.18).

Johnson Matthey Company Profile (LON:JMAT)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Article: Diluted Earnings Per Share

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with's FREE daily email newsletter.